FDA Inspection 1240230 — Texas Health Presbyterian Hospital Of Dallas Blood Bank
The FDA completed an inspection of Texas Health Presbyterian Hospital Of Dallas Blood Bank on May 24, 2024 in Dallas, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- May 24, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Dallas, TX (United States)